Clifford Swan Investment Counsel’s CVS Health CVS Stock Holding History

Clifford Swan Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Buy	2,861 +2	+0.1%	+$179	0.01%	288
2026 Q1	$205K	Sell	2,859 -575	-17%	-$44.3K	0.01%	325
2025 Q4	$273K	Sell	3,434 -27	-0.8%	-$2.13K	0.01%	280
2025 Q3	$261K	Sell	3,461 -8	-0.2%	-$548	0.01%	292
2025 Q2	$239K	Buy	3,469 +8	+0.2%	+$525	0.01%	292
2025 Q1	$234K	Buy	+3,461	New	+$207K	0.01%	294
2024 Q4	–	Sell	-4,078	Closed	-$256K	–	309
2024 Q3	$256K	Buy	4,078 +275	+7%	+$16K	0.01%	288
2024 Q2	$225K	Sell	3,803 -1,284	-25%	-$80.3K	0.01%	289
2024 Q1	$406K	Sell	5,087 -189	-4%	-$14.4K	0.02%	238
2023 Q4	$417K	Sell	5,276 -187	-3%	-$13.3K	0.02%	228
2023 Q3	$381K	Sell	5,463 -790	-13%	-$56K	0.02%	232
2023 Q2	$432K	Buy	6,253 +574	+10%	+$40.8K	0.02%	223
2023 Q1	$422K	Sell	5,679 -4	-0.1%	-$335	0.02%	222
2022 Q4	$530K	Sell	5,683 -697	-11%	-$67.3K	0.02%	208
2022 Q3	$608K	Sell	6,380 -102	-2%	-$10.1K	0.03%	197
2022 Q2	$601K	Buy	6,482 +371	+6%	+$36.2K	0.03%	205
2022 Q1	$618K	Sell	6,111 -298	-5%	-$31.3K	0.02%	214
2021 Q4	$661K	Buy	6,409 +2,936	+85%	+$271K	0.02%	218
2021 Q3	$315K	Hold	3,473	–	–	0.01%	276
2021 Q2	$283K	Hold	3,473	–	–	0.01%	283
2021 Q1	$261K	Buy	+3,473	New	+$253K	0.01%	292
2020 Q3	–	Sell	-3,609	Closed	-$234K	–	316
2020 Q2	$234K	Sell	3,609 -798	-18%	-$50.3K	0.01%	279
2020 Q1	$261K	Sell	4,407 -124	-3%	-$8.28K	0.02%	255
2019 Q4	$337K	Buy	4,531 +947	+26%	+$66.5K	0.02%	254
2019 Q3	$226K	Sell	3,584 -600	-14%	-$35.6K	0.01%	280
2019 Q2	$228K	Sell	4,184 -7,763	-65%	-$418K	0.01%	292
2019 Q1	$644K	Hold	11,947	–	–	0.03%	188
2018 Q4	$783K	Hold	11,947	–	–	0.05%	166
2018 Q3	$940K	Buy	11,947 +4,077	+52%	+$291K	0.05%	161
2018 Q2	$506K	Sell	7,870 -1,832	-19%	-$121K	0.03%	204
2018 Q1	$604K	Buy	9,702 +325	+3%	+$23.3K	0.03%	193
2017 Q4	$680K	Buy	9,377 +3,842	+69%	+$279K	0.04%	191
2017 Q3	$450K	Buy	5,535 +190	+4%	+$15K	0.03%	216
2017 Q2	$430K	Buy	5,345 +1,718	+47%	+$136K	0.03%	225
2017 Q1	$285K	Buy	3,627 +522	+17%	+$41.7K	0.02%	248
2016 Q4	$245K	Buy	3,105 +20	+0.6%	+$1.62K	0.02%	245
2016 Q3	$275K	Hold	3,085	–	–	0.02%	237
2016 Q2	$295K	Sell	3,085 -300	-9%	-$29.9K	0.02%	222
2016 Q1	$351K	Hold	3,385	–	–	0.02%	216
2015 Q4	$331K	Buy	3,385 +510	+18%	+$49.9K	0.02%	223
2015 Q3	$277K	Sell	2,875 -75	-3%	-$7.88K	0.02%	226
2015 Q2	$309K	Hold	2,950	–	–	0.02%	217
2015 Q1	$304K	Hold	2,950	–	–	0.02%	220
2014 Q4	$284K	Hold	2,950	–	–	0.02%	224
2014 Q3	$235K	Buy	+2,950	New	+$233K	0.02%	231

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Clifford Swan Investment Counsel's CVS Position: Q2 2026 in Review

Clifford Swan Investment Counsel increased its CVS Health (CVS) stake by 0.07% in Q2 2026, buying an estimated $179 and bringing the position to 2,861 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #288.

Clifford Swan Investment Counsel first reported a position in CVS in Q3 2014 and has held it in 45 quarters since. The position peaked at $940K in Q3 2018. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Clifford Swan Investment Counsel held 2,861 shares of CVS Health worth $296K as of Q2 2026.
Clifford Swan Investment Counsel bought 2 CVS Health shares in Q2 2026, an estimated $179.
CVS Health made up 0.01% of Clifford Swan Investment Counsel's portfolio in Q2 2026, its #288 holding.
Clifford Swan Investment Counsel first reported a position in CVS Health in Q3 2014 and has held it in 45 quarters since.
Clifford Swan Investment Counsel's CVS Health position peaked at $940K in Q3 2018.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2026, filed 20 Aug 2026.